Search the Community
Showing results for tags 'stampede trial'.
Found 2 results
This is a 7 minute video covering an Interview of Dr Neeraj Agarwal MD by Dr Farzanna S Haffizulla MD,FACP, FAMWA It was recorded in September 2017. It is on the Practice today Web Site. It compares Docetaxel with Abiraterone, Enzalutamide and Tak700 ( TAK-700 is sort of a cousin of abiraterone) which doesn't require concomitant use of prednisone). To see video click the link below. http://c.brightcove.com/services/mobile/streaming/index/rendition.m3u8?assetId=5547296943001&pubId=2421677169001&videoId=5469577148001
Paul Edwards posted a topic in Articles on other sitesThe New Prostate Cancer Infolink reports Full data on ADT + chemotherapy from the STAMPEDE trial now published The report has links to the full text of articles in the Lancet regarding this research. "For men with metastatic prostate cancer starting [androgen deprivation] therapy for the first time, we found strong evidence to support the addition of docetaxel to androgen deprivation therapy as the new standard of care, and this combination should be offered to men who are fit to receive chemotherapy. " There is no sufficient evidence yet to recommend docetaxel plus androgen deprivation therapy for hormone-naive men men diagnosed with micrometastatic prostate cancer (cancer in the lymph nodes but not yet metastasised to the bone - M0)